Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“And that’s a wrap! A pleasure to have been able to serve on the Scientific Committee of ESMO – European Society for Medical Oncology ESMO Rare Cancers 2o26 successfully held in beautiful Lugano over the last 3 days!
Lots of science and fruitful conversations with Хэштег#colleagues dedicated to advancing the science and outcomes of rare cancers and sarcomas from around the world.
Mark your calendars for March4-6, 2027!”
Other articles about ESMO on OncoDaily.
